These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23964937)

  • 21. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
    Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ;
    Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
    Danese S
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 25. How effective is the use of long-term anti-TNF for paediatric IBD? Clues from real-life surveillance cohorts.
    Topf-Olivestone C; Turner D
    Arch Dis Child; 2015 Apr; 100(4):391-2. PubMed ID: 25784738
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
    Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
    Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
    Danese S; Angelucci E
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing guidelines for the treatment of inflammatory bowel disease.
    Hanauer SB; Kirsner JB
    Dig Dis; 2013; 31(3-4):360-2. PubMed ID: 24246988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in the efficacy, optimization and safety of treatments for inflammatory bowel disease].
    Chaparro M
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():57-67. PubMed ID: 23018009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease.
    Koutroubakis IE; Oustamanolakis P; Malliaraki N; Karmiris K; Chalkiadakis I; Ganotakis E; Karkavitsas N; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):283-8. PubMed ID: 19279474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella zoster exposure in patients with inflammatory bowel disease--recall is not enough.
    Aggarwal D; Limdi JK
    Am J Gastroenterol; 2014 Mar; 109(3):448-9. PubMed ID: 24594962
    [No Abstract]   [Full Text] [Related]  

  • 33. New therapeutic approach in inflammatory bowel disease.
    Papa A; Mocci G; Scaldaferri F; Bonizzi M; Felice C; Andrisani G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():33-5. PubMed ID: 19530509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
    D'Haens G; Feagan B; Colombel JF; Sandborn WJ; Reinisch W; Rutgeerts P; Carbonnel F; Mary JY; Danese S; Fedorak RN; Hanauer S; Lémann M;
    Gastroenterology; 2012 Dec; 143(6):1461-9. PubMed ID: 23000597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease.
    Hayashi H; Kuwabara C; Tarumi K; Makino E; Fujimoto W
    J Dermatol; 2012 Jun; 39(6):576-8. PubMed ID: 21958000
    [No Abstract]   [Full Text] [Related]  

  • 36. [Commentaries on the article "are there frequent errors in the management of outpatients with inflammatory bowel disease?"].
    Sánchez-Muñoz D; Castro-Fernández M
    Gastroenterol Hepatol; 2008 Apr; 31(4):265. PubMed ID: 18405494
    [No Abstract]   [Full Text] [Related]  

  • 37. Reader response: antitumor necrosis factor therapy.
    Heath PK; Athwal D; Jones S
    Inflamm Bowel Dis; 2000 Feb; 6(1):70. PubMed ID: 10701157
    [No Abstract]   [Full Text] [Related]  

  • 38. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
    Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor necrosis factor inhibitors: following best practice.
    White B
    Manag Care; 2005 May; 14(5 Suppl):17-23. PubMed ID: 15962833
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
    Casanova MJ; Chaparro M; Domènech E; Barreiro-de Acosta M; Bermejo F; Iglesias E; Gomollón F; Rodrigo L; Calvet X; Esteve M; García-Planella E; García-López S; Taxonera C; Calvo M; López M; Ginard D; Gómez-García M; Garrido E; Pérez-Calle JL; Beltrán B; Piqueras M; Saro C; Botella B; Dueñas C; Ponferrada A; Mañosa M; García-Sánchez V; Maté J; Gisbert JP
    Am J Gastroenterol; 2013 Mar; 108(3):433-40. PubMed ID: 23318480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.